Access our complete catalogue of cancer immunotherapy clinical practice guidelines using the SITC CPG Mobile App.
Sept. 29–30, 2021 • Online
The safety of our attendees at our in-person events is of the utmost importance at the Society for Immunotherapy of Cancer (SITC). Given the recent increase in the COVID-19 virus and the desire to keep everyone as safe as possible, Interrogating the Tumor-Specific Surfaceome for Immune Targeting Workshop, Sept. 29–30 2021 will now be held virtually.SITC invites you to attend the virtual workshop, Interrogating the Tumor-Specific Surfaceome for Immune Targeting Workshop. This workshop will focus on the tumor cell surfaceome and the many opportunities that accompany it for the development of future immunotherapies and maximization of existing techniques. By bringing together experts on the topic from a variety of fields including medical oncology, bioinformatics, cancer biology, genetics/epigenetics, immunology, and many others, the workshop will facilitate increased discussion in this important area. The virtual format assures a compelling program that can be held safely and successfully, and allows us to accommodate as many participants as possible.To thank you for your continued interest in this workshop given the postponement in 2020 and now a switch to a virtual format, we are happy to be able to offer a 50 percent discount on the registration rate. Register today at the special new rate!Concepts ranging from the basic biology of cancer cell surface molecules to applications of drugs and cellular therapies targeting novel surface markers will be discussed, with the goal of defining the future direction of the field. It is anticipated that the efforts of this workshop will fuel innovative collaborations, disseminate important knowledge to the rest of the immunotherapy field, and help assure the continued growth of immunotherapy treatments as a whole.
Four slots for oral abstract presentations are available during this workshop.
Posters will be presented during the Poster Reception. Poster specifications will be based on the number of abstracts that will be presented and will be provided with acceptance notifications. The presenting author is responsible for printing, bringing and hanging up their poster. SITC does not provide printing services on-site, or special accommodations for disposing of or shipping posters after the workshop.
For more information on abstract guidelines and policies, please click here.
VIEW ABSTRACT SUBMISSION GUIDE
Immediately following the Surfaceome Virtual Workshop, SITC is hosting a unique workshop, Bispecific T cell Engagers Virtual Workshop, focused on T cell engager biology and therapeutic strategies including target selection, therapeutic engineering and design features, cytotoxicity vs cytokine release, impact of the tumor microenvironment, and advances in conditionally-active binding.A collaborative session, taking place the morning of Sept. 30, will allow attendees from both workshops to discuss alignment and debates in the areas of the two workshops with the focus on how to continue to advance the field.It is anticipated that the efforts of these workshops will fuel innovative collaborations, disseminate important knowledge to the rest of the immunotherapy field, and help assure the continued growth of immunotherapy treatments as a whole.Participants will receive a discount when registering for both the Bispecific T cell Engagers Workshop and the Surfaceome Workshop.
view Or Purchase enduring materialsEnduring materials are available as permitted by presenters. Click here to view the program schedule along with presenter's permission to post materials.Program registrants receive complimentary access to on-demand content. Enduring materials are available for purchase for those who did not register to attend the program. A discount is available for SITC Members. Renew your dues or become a SITC member today.
If you have questions about this program, please contact the SITC Education team.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com